Congress Asset Management Co. Has $154.88 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Congress Asset Management Co. increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.7% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 312,708 shares of the medical equipment provider's stock after purchasing an additional 5,078 shares during the period. Intuitive Surgical comprises about 1.2% of Congress Asset Management Co.'s investment portfolio, making the stock its 15th largest position. Congress Asset Management Co. owned about 0.09% of Intuitive Surgical worth $154,875,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of ISRG. Vanguard Group Inc. boosted its stake in Intuitive Surgical by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock valued at $16,813,478,000 after buying an additional 360,591 shares in the last quarter. Geode Capital Management LLC boosted its stake in Intuitive Surgical by 3.2% in the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider's stock valued at $4,039,200,000 after buying an additional 243,802 shares in the last quarter. Fisher Asset Management LLC boosted its stake in Intuitive Surgical by 1.8% in the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider's stock valued at $2,541,356,000 after buying an additional 86,488 shares in the last quarter. Norges Bank acquired a new stake in Intuitive Surgical in the 4th quarter valued at $2,401,493,000. Finally, Invesco Ltd. boosted its stake in Intuitive Surgical by 7.7% in the 4th quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider's stock valued at $2,165,184,000 after buying an additional 295,025 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the sale, the director now directly owns 6,371 shares in the company, valued at $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Mark Brosius sold 216 shares of the stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the sale, the senior vice president now owns 907 shares of the company's stock, valued at $510,740.77. This trade represents a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 25,443 shares of company stock valued at $12,692,195. 0.70% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several analysts recently commented on ISRG shares. Royal Bank of Canada decreased their price target on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Citigroup reissued a "buy" rating and issued a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the stock a "buy" rating in a research note on Monday, April 14th. Truist Financial reduced their price objective on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. Finally, Piper Sandler reduced their price objective on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. Four research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat, Intuitive Surgical has a consensus rating of "Moderate Buy" and a consensus target price of $596.05.

Intuitive Surgical Stock Down 0.2%

NASDAQ ISRG traded down $0.98 on Friday, reaching $557.08. The company had a trading volume of 1,103,774 shares, compared to its average volume of 1,641,815. Intuitive Surgical, Inc. has a 52 week low of $413.52 and a 52 week high of $616.00. The stock's 50 day moving average is $521.99 and its 200-day moving average is $539.26. The stock has a market cap of $199.67 billion, a price-to-earnings ratio of 86.91, a PEG ratio of 5.85 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the prior year, the firm posted $1.50 earnings per share. As a group, analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.